As proof of principle that the TG2-FN-Iβ1 complex represents an interesting target in OC, we used a function-blocking antibody which targeted the FN binding domain of TG2, and showed that this antibody blocked OC spheroid proliferation and tumor initiating capacity by disrupting the interaction between OC stem cells and their niche [103]. The gene discussed is FN1; the disease is neoplasm.